118 related articles for article (PubMed ID: 1690960)
1. Myoclonic seizure activity with chronic high-dose spinal opioid administration.
Parkinson SK; Bailey SL; Little WL; Mueller JB
Anesthesiology; 1990 Apr; 72(4):743-5. PubMed ID: 1690960
[No Abstract] [Full Text] [Related]
2. Inpatient narcotic infusions for patients with cancer pain.
Ferris FD; Kerr IG; De Angelis C; Sone M; Hume S
J Palliat Care; 1990; 6(2):51-9. PubMed ID: 1695950
[TBL] [Abstract][Full Text] [Related]
3. Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride.
Katcher J; Walsh D
J Pain Symptom Manage; 1999 Jan; 17(1):70-2. PubMed ID: 9919868
[TBL] [Abstract][Full Text] [Related]
4. Opioid withdrawal syndrome on switching from hydromorphone to alfentanil.
McMunnigall F; Welsh J
Palliat Med; 2008 Mar; 22(2):191-2. PubMed ID: 18372384
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report.
Cabbell KL; Taren JA; Sagher O
Neurosurgery; 1998 May; 42(5):1176-80; discussion 1180-1. PubMed ID: 9588567
[TBL] [Abstract][Full Text] [Related]
6. Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study.
Marroquin B; Feng C; Balofsky A; Edwards K; Iqbal A; Kanel J; Jackson M; Newton M; Rothstein D; Wong E; Wissler R
Int J Obstet Anesth; 2017 May; 30():16-22. PubMed ID: 28185794
[TBL] [Abstract][Full Text] [Related]
7. Relative analgesic potencies of morphine and hydromorphone in postoperative pain.
Mahler DL; Forrest WH
Anesthesiology; 1975 May; 42(5):602-7. PubMed ID: 48347
[TBL] [Abstract][Full Text] [Related]
8. Seizures associated with high-dose intravenous morphine containing sodium bisulfite preservative.
Meisel SB; Welford PK
Ann Pharmacother; 1992 Dec; 26(12):1515-7. PubMed ID: 1482805
[TBL] [Abstract][Full Text] [Related]
9. Contribution to variability in response to opioids.
Hanks GW; Reid C
Support Care Cancer; 2005 Mar; 13(3):145-52. PubMed ID: 15761703
[TBL] [Abstract][Full Text] [Related]
10. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
[TBL] [Abstract][Full Text] [Related]
11. Decreased local toxicity with subcutaneous diamorphine (heroin): a preliminary report.
Bruera E; Macmillan K; Selmser P; MacDonald NR
Pain; 1990 Oct; 43(1):91-94. PubMed ID: 1703651
[TBL] [Abstract][Full Text] [Related]
12. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
13. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
15. Analgesia after Cesarean delivery: a retrospective comparison of intrathecal hydromorphone and morphine.
Beatty NC; Arendt KW; Niesen AD; Wittwer ED; Jacob AK
J Clin Anesth; 2013 Aug; 25(5):379-383. PubMed ID: 23965210
[TBL] [Abstract][Full Text] [Related]
16. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
[TBL] [Abstract][Full Text] [Related]
17. Opioid hyperexcitability: the application of alternate opioid therapy.
MacDonald N; Der L; Allan S; Champion P
Pain; 1993 Jun; 53(3):353-355. PubMed ID: 7688888
[TBL] [Abstract][Full Text] [Related]
18. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
Du Pen S; Du Pen A; Hillyer J
Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
[TBL] [Abstract][Full Text] [Related]
20. Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series.
Veizi E; Tornero-Bold M; Hayek SM
Pain Pract; 2016 Jul; 16(6):E94-8. PubMed ID: 26990069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
